Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Macgregor

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
The Journal of Infectious Diseases|July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host responseR R MacGregor, J D Boyer, K E Ugen, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trialJ D Boyer, M A Chattergoon, K E Ugen, et al.
Nuclear Medicine and Biology|October 2, 2001
Species differences in [11C]clorgyline binding in brainJ S Fowler, Y S Ding, J Logan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253S Swindells, L Komarow, S Tripathy, et al.
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDSD V Havlir, M P Dubé, J A McCutchan, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
The Journal of Infectious Diseases|July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host responseR R MacGregor, J D Boyer, K E Ugen, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trialJ D Boyer, M A Chattergoon, K E Ugen, et al.
Nuclear Medicine and Biology|October 2, 2001
Species differences in [11C]clorgyline binding in brainJ S Fowler, Y S Ding, J Logan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253S Swindells, L Komarow, S Tripathy, et al.
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDSD V Havlir, M P Dubé, J A McCutchan, et al.
Pageof 24